EMEA-001212-PIP01-11

Key facts

Invented name
Kineret
Active substance
anakinra
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0066/2012
PIP number
EMEA-001212-PIP01-11
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, psoriatic arthritis, ankylosing
  • Treatment of cryopyrin-associated periodic syndromes (CAPS)
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Swedish Orphan Biovitrum AB
christina.rickhammar@sobi.com
Country: Sweden
Phone: +46 86972000
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number
EMEA-C-001212-PIP01-11
Compliance opinion date
12/12/2014
Compliance outcome
positive

Decision

How useful was this page?

Add your rating